Skip to content

Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)

Effectiveness of a Physical Activity and Diet Program, Coordinated Between Primary Care and Mental Health, to Modify Cardiovascular Risk Factors in Patients With Schizophrenia or Bipolar Disorder (CapiCor)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01729650
Acronym
CapiCor
Enrollment
332
Registered
2012-11-20
Start date
2012-06-30
Completion date
2015-12-31
Last updated
2016-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorders, Schizoaffective Disorders, Schizophrenic Disorders

Keywords

Psychotic Disorders,, Heart Diseases

Brief summary

The aim is to evaluate the effectiveness of an intervention based on a program of physical activity and diet coordinated between primary care teams (PCT) and Mental Health Centres (MHC) to modify the weekly physical activity (PA) amount, body mass index (BMI) and waist circumference in patients with severe mental disorder diagnoses. To assess changes in cardiovascular risk, quality of life and lifestyles, secondarily. Methods: A randomized clinical trial with a control group, of one year of follow-up, carried out in four MHC Barcelona and Santa Coloma, and PCT of reference. The investigators studied patients aged 18 - 65 years old, diagnosed with schizophrenia, schizoaffective or bipolar disorder, with antipsychotic medication and a low level of PA. 240 patients will be selected in each group (difference to be detected in the BMI:\> 1.89 kg/m2; common SD: 6.2, 30% loss). Intervention: group educational PA program (basically walking) of 24 sessions over 12 weeks, and diet (8 sessions in the first 8 weeks) by nurses and specialists in PA. Key measurements: level of PA (IPAQ questionnaire), physical examinations: BMI, waist circumference, blood pressure, cardiovascular risk, quality of life (SF-36), smoking habits, dietary habits (PREDIMED questionnaire), analytical parameters: cholesterol , triglycerides, blood glucose. Evaluations will be masked and conducted at 0, 3, 6 and 12 months. Analysis of variance for repeated measures to adjust for differences attributable to the effect of the intervention for potential confounders: pharmacological treatment, care level of intervention and mental state.

Interventions

BEHAVIORALPhysical and diet educational group

educational group of: physical activity program (basically walking) of 24 sessions over 12 weeks, and diet (16 sessions in the first 8 weeks, carried out by mental health nurses.

Sponsors

Carlos III Health Institute
CollaboratorOTHER_GOV
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 65 years old, * understand Catalan or Spanish * will be located for at least twelve months. * Psychiatric disorders with ICD-10 diagnosis codes: F20\*, F31\* and F25\*. * Taking an antipsychotic drug at, a least, three months * Low physical activity level

Exclusion criteria

* Active addiction to psychoactive drugs, except tobacco. * Pregnancy * Diseases that doesn't allow physical activity * Psychotic acute exacerbation in the last month

Design outcomes

Primary

MeasureTime frame
waist circumference (cm): the outcome measure is studied at 3, 6 and 12 months
Body mass index (kg/m²): the outcome measure is studied at 3, 6 and 12 months
Change in weekly level of physical activity (IPAQ questionnaire),: the outcome measure is studied at 3, 6 and 12 months

Secondary

MeasureTime frame
Quality of life (SF-36 questionnaire)the outcome measure is studied at 3, 6 and 12 months
Dietary habits (PREDIMED questionnaire)the outcome measure is studied at 3, 6 and 12 months
Analytical parameters: cholesterol , triglycerides, blood glucose mg/100 ml.the outcome measure is studied at 3, 6 and 12 months
Smoking habits: smoker/ ex-smoker/no-smoker. Number of cigarettes per day.the outcome measure is studied at 3, 6 and 12 months
blood pressure (mm hg)the outcome measure is studied at 3, 6 and 12 months
cardiovascular risk with the Regicor coronary risk to 10 yearsthe outcome measure is studied at 3, 6 and 12 months

Other

MeasureTime frame
Clinical Global Impression, CGIthe outcome measure is studied at 3, 6 and 12 months
BPRS (Brief Psychiatric Rating Scale)the outcome measure is studied at 3, 6 and 12 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026